These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 3956557)
1. Evaluating and designing cancer chemotherapy treatment using mathematical models. Birkhead BG; Gregory WM; Slevin ML; Harvey VJ Eur J Cancer Clin Oncol; 1986 Jan; 22(1):3-8. PubMed ID: 3956557 [No Abstract] [Full Text] [Related]
2. A mathematical model of the development of drug resistance to cancer chemotherapy. Birkhead BG; Rankin EM; Gallivan S; Dones L; Rubens RD Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1421-7. PubMed ID: 3678329 [TBL] [Abstract][Full Text] [Related]
3. On mathematical modeling of critical variables in cancer treatment (goals: better understanding of the past and better planning in the future). Skipper HE Bull Math Biol; 1986; 48(3-4):253-78. PubMed ID: 3828557 [No Abstract] [Full Text] [Related]
4. The evolution of curative cancer therapy. Frei E Mt Sinai J Med; 1992 Oct; 59(5):408-11. PubMed ID: 1435837 [No Abstract] [Full Text] [Related]
5. Concepts for the treatment of tumor metastasis. Griswold DP; Schabel FM; Dykes DJ; Trader MW; Laster WR Symp Fundam Cancer Res; 1983; 36():389-96. PubMed ID: 6382515 [No Abstract] [Full Text] [Related]
6. Mathematical approaches to optimization of cancer chemotherapy. Zietz S; Nicolini C Bull Math Biol; 1979; 41(3):305-24. PubMed ID: 465827 [No Abstract] [Full Text] [Related]
7. [Strategies for the overcoming of drug resistance]. Saijo N Gan To Kagaku Ryoho; 1995 Feb; 22(3):371-81. PubMed ID: 7880108 [TBL] [Abstract][Full Text] [Related]
8. Role of mathematical modeling in protocol formulation in cancer chemotherapy. Coldman AJ; Goldie JH Cancer Treat Rep; 1985 Oct; 69(10):1041-8. PubMed ID: 2412691 [TBL] [Abstract][Full Text] [Related]
9. Implications of certain cell kinetic and biological parameters for preoperative chemotherapy. Hill BT Recent Results Cancer Res; 1986; 103():41-53. PubMed ID: 3526475 [No Abstract] [Full Text] [Related]
10. What does not kill a tumour may make it stronger: In silico insights into chemotherapeutic drug resistance. Hamis S; Nithiarasu P; Powathil GG J Theor Biol; 2018 Oct; 454():253-267. PubMed ID: 29909142 [TBL] [Abstract][Full Text] [Related]
11. When less is more. Kaiser J Science; 2017 Mar; 355(6330):1144-1146. PubMed ID: 28302821 [No Abstract] [Full Text] [Related]
12. Mechanisms to improve chemotherapy effectiveness. Young RC Cancer; 1990 Feb; 65(3 Suppl):815-22. PubMed ID: 2406004 [TBL] [Abstract][Full Text] [Related]
14. Cancer chemotherapy. Secchi GC Ann Ital Med Int; 1990; 5(3 Pt 3):288-95. PubMed ID: 2081089 [TBL] [Abstract][Full Text] [Related]
15. Response surface methodology and the design of clinical trials for the evaluation of cancer chemotherapy. Carter WH Cancer Treat Rep; 1985 Oct; 69(10):1049-53. PubMed ID: 4042084 [No Abstract] [Full Text] [Related]
17. Dose-response relationship in experimental and clinical oncology. Brade WP; Freireich EJ; Goldin A Cancer Treat Rev; 1984 Dec; 11(4):279-83. PubMed ID: 6398757 [No Abstract] [Full Text] [Related]
18. [Prevention of resistance to chemotherapy in the therapeutic strategy for cancer]. Droz JP Bull Cancer; 1994 Dec; 81 Suppl 2():91s-94s. PubMed ID: 7727869 [No Abstract] [Full Text] [Related]
19. Modelling chemotherapy resistance in palliation and failed cure. Monro HC; Gaffney EA J Theor Biol; 2009 Mar; 257(2):292-302. PubMed ID: 19135065 [TBL] [Abstract][Full Text] [Related]
20. Drug resistance as a dynamic process in a model for multistep gene amplification under various levels of selection stringency. Harnevo LE; Agur Z Cancer Chemother Pharmacol; 1992; 30(6):469-76. PubMed ID: 1394803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]